Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Observational, Cross-Sectional, Multicenter Study to Estimate the Prevalence of an Eosinophilic Phenotype Among Severe Asthma Patients in Brazil

NCT03925415 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03925415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Observational, Cross-Sectional, Multicenter Study to Estimate the Prevalence of an Eosinophilic Phenotype Among Severe Asthma Patients in Brazil
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 24, 2019
Completion date
October 15, 2019
Enrollment
414 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma